On Nov. 20-21, 2019, Greenberg Traurig participated in and sponsored the Israel Hotel Investment Summit in Tel Aviv, Israel. Washington, D.C. office Shareholder and Hospitality Practice Co-Chair Nelson Migdal joined a panel, together with representatives of leading international hotel brands, on the benefits of international brand penetration into the Israel hotel market, as well as legal structuring and operational models for hotels in Israel. Attended by more than 200 professionals from Europe, the United States, and Israel, the conference demonstrated Israel’s status as a major international hospitality destination. Tel Aviv office Managing Shareholder Joey Shabot (M&A), Shareholder Lawrence Sternthal (Real Estate), and Associate Saar Warner-Lipton (Real Estate) also attended the summit.

Here are the top five highlights:
Continue Reading The Israel Hotel Investment Summit: Take Five!

Congratulations to our long-standing client Amadeus upon its investment in Refundit, an Israeli startup which is developing a mobile solution to make it easier for travelers to get their VAT
Continue Reading Amadeus leads a $9.8M investment round in Refundit to digitalize VAT refunds for travelers worldwide

Israeli communications tech startup NSLComm launched its first nano-satellite, the NSLSat-1, into space on Friday, July 5, fitted with an innovative antenna that expands and offers high performance and affordability.
Continue Reading NSLComm Launches 1st Nano-Satellite Fitted With Expanding Antenna Into Space

Global law firm Greenberg Traurig, led by Tel Aviv office Managing Shareholder Joey T. Shabot and Of Counsel Ephraim Schmeidler, represented Volvo Group Venture Capital in its investment in
Continue Reading Greenberg Traurig Represents Volvo Group Venture Capital in Mobility Start-Ups Investment

Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life
Continue Reading Tel Aviv Office to Host Capital Markets Roundtable for the Life Sciences Industry